Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors
Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the...
Main Authors: | , |
---|---|
Format: | Article |
Language: | fas |
Published: |
Isfahan University of Medical Sciences
2011-03-01
|
Series: | مجله دانشکده پزشکی اصفهان |
Subjects: | |
Online Access: | http://jims.mui.ac.ir/index.php/jims/article/view/704 |
_version_ | 1827838117308006400 |
---|---|
author | Farzad Gheshlaghi Zohreh Sedighinia |
author_facet | Farzad Gheshlaghi Zohreh Sedighinia |
author_sort | Farzad Gheshlaghi |
collection | DOAJ |
description | Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the clinical signs of two types of poisoning.
Methods: In this cross-sectionsl study, 167 patients with pyrethroids poisoning and 167 patients with cholinesterase inhibitors poisoning refered to Noor hospital, Isfahan were assessed. The patients were selected by simple sampelling method and were clinically examined.
Finding: The mean age of patients with pyrethroids poisoning was 22.47 and of patients with cholinesterase inhibitors poisoning was 28.80 years. In both groups, men were more than women and poisening by eating was the most prevalent way. The intentional cases were more than accidental ones. The most prevalent signs of cholinesterase inhibitors poisoning were nausea (68.9%), vomiting (43.1%), diarrhea (43.1%), myosis (40.7%), sweating (38.3%) and sialorrhea (36.5%) respectively; also, the most prevalent signs of pyrethroids poisoning were nausea (74.9%), vomiting (61.7%), abdominal cramp (20%), sialorrhea (15.6%), and muscle weakness (12.6%) respectively.
Conclusion: Based on this study, the difference between these two types of poisoning symptoms can help the differential diagnosis. |
first_indexed | 2024-03-12T06:59:26Z |
format | Article |
id | doaj.art-d03f59ef72d547b1b5a80b795a4a612b |
institution | Directory Open Access Journal |
issn | 1027-7595 1735-854X |
language | fas |
last_indexed | 2024-03-12T06:59:26Z |
publishDate | 2011-03-01 |
publisher | Isfahan University of Medical Sciences |
record_format | Article |
series | مجله دانشکده پزشکی اصفهان |
spelling | doaj.art-d03f59ef72d547b1b5a80b795a4a612b2023-09-02T23:49:35ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2011-03-0128115963968491Clinical Signs of Poisoning with Pyrethroid and Cholinesterase InhibitorsFarzad Gheshlaghi0Zohreh Sedighinia1Associate Professor, Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Medical Student, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.Background: Due to the similarities between clinical signs of toxicity with pyrethroids and cholinesterase inhibitors, if the mistake between these two was made and the patient was treatment with atropine, severe atropine poisoning and even death could occur. This study was conducted to compare the clinical signs of two types of poisoning. Methods: In this cross-sectionsl study, 167 patients with pyrethroids poisoning and 167 patients with cholinesterase inhibitors poisoning refered to Noor hospital, Isfahan were assessed. The patients were selected by simple sampelling method and were clinically examined. Finding: The mean age of patients with pyrethroids poisoning was 22.47 and of patients with cholinesterase inhibitors poisoning was 28.80 years. In both groups, men were more than women and poisening by eating was the most prevalent way. The intentional cases were more than accidental ones. The most prevalent signs of cholinesterase inhibitors poisoning were nausea (68.9%), vomiting (43.1%), diarrhea (43.1%), myosis (40.7%), sweating (38.3%) and sialorrhea (36.5%) respectively; also, the most prevalent signs of pyrethroids poisoning were nausea (74.9%), vomiting (61.7%), abdominal cramp (20%), sialorrhea (15.6%), and muscle weakness (12.6%) respectively. Conclusion: Based on this study, the difference between these two types of poisoning symptoms can help the differential diagnosis.http://jims.mui.ac.ir/index.php/jims/article/view/704Clinical symptomsToxicityPyrethroidCholinesterase inhibitors |
spellingShingle | Farzad Gheshlaghi Zohreh Sedighinia Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors مجله دانشکده پزشکی اصفهان Clinical symptoms Toxicity Pyrethroid Cholinesterase inhibitors |
title | Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors |
title_full | Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors |
title_fullStr | Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors |
title_full_unstemmed | Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors |
title_short | Clinical Signs of Poisoning with Pyrethroid and Cholinesterase Inhibitors |
title_sort | clinical signs of poisoning with pyrethroid and cholinesterase inhibitors |
topic | Clinical symptoms Toxicity Pyrethroid Cholinesterase inhibitors |
url | http://jims.mui.ac.ir/index.php/jims/article/view/704 |
work_keys_str_mv | AT farzadgheshlaghi clinicalsignsofpoisoningwithpyrethroidandcholinesteraseinhibitors AT zohrehsedighinia clinicalsignsofpoisoningwithpyrethroidandcholinesteraseinhibitors |